Fisher & Paykel Healthcare Corporation Limited (FSPKF)
OTCMKTS
· Delayed Price · Currency is USD
20.70
0.00 (0.00%)
Jun 25, 2025, 8:00 PM EDT
FSPKF Revenue
In the fiscal year ending March 31, 2025, Fisher & Paykel Healthcare Corporation had annual revenue of 2.02B NZD with 15.96% growth. Fisher & Paykel Healthcare Corporation had revenue of 1.07B in the half year ending March 31, 2025, with 20.13% growth.
Revenue
2.02B NZD
Revenue Growth
+15.96%
P/S Ratio
11.34
Revenue / Employee
271.64K NZD
Employees
7,440
Market Cap
12.99B USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.02B | 278.20M | 15.96% |
| Mar 31, 2024 | 1.74B | 161.70M | 10.23% |
| Mar 31, 2023 | 1.58B | -100.60M | -5.98% |
| Mar 31, 2022 | 1.68B | -289.50M | -14.69% |
| Mar 31, 2021 | 1.97B | 707.50M | 55.99% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Fisher & Paykel Healthcare Corporation News
- 4 weeks ago - Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Fisher & Paykel Healthcare Corporation Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - ASX 200 LIVE: April CPI holds at 2.4pc; MIN shares sink on lower iron ore guidance; sharemarket rises as Nasdaq, S&P 500 rally on Trump-EU trade talk hopes - The Australian Financial Review
- 5 months ago - Trump tariffs hit the ASX with Fisher & Paykel dragged into storm - The Australian Financial Review
- 5 months ago - Fisher & Paykel Healthcare says US tariffs will increase costs, but sees no impact on profit - NZ Herald
- 7 months ago - Fisher & Paykel Healthcare Corp Ltd (FSPKF) (H1 2025) Earnings Call Highlights: Strong ... - GuruFocus
- 7 months ago - Half Year 2025 Fisher & Paykel Healthcare Corporation Ltd Earnings Call Transcript - GuruFocus
- 7 months ago - Fisher & Paykel misses high market hopes, sticks to guidance - The Australian Financial Review